Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “INOVIO”

75 pharma patents match "INOVIO" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 75
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 75 pharmaceutical patents matching "INOVIO" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

75 results for “INOVIO” · 30,257 patents in full index Clear search

  1. US 11565107

    Tolerable and minimally invasive skin electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  2. US 11464841

    TERT immunogenic compositions and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  3. US 11338028

    Cancer vaccines targeting LEMD1 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  4. US 11338029

    Cancer vaccines targeting PRAME and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted May 24, 2022 · Expires May 19, 2042

    granted

  5. US 11291836

    Minimally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  6. US 11278619

    DNA antibody constructs and method of using same

    Inovio Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  7. US 11235044

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  8. US 11230592

    DNA antibody constructs for use against middle east respiratory syndrome coronavirus

    Inovio Pharmaceuticals, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  9. US 11208470

    DNA antibody constructs and method of using same

    Inovio Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  10. US 11154602

    Cancer vaccines targeting mesothelin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  11. US 11154601

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  12. US 11135284

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  13. US 11124545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  14. US 11116838

    Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  15. US 11091518

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Inovio Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  16. US 11045535

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  17. US 11027071

    Intradermal jet injection electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  18. US 11007265

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  19. US 11007255

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  20. US 10933130

    Vaccines with interleukin-33 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  21. US 10925961

    Vaccines with CD40 ligand as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  22. US 10905755

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  23. US 10835595

    PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  24. US 10668279

    Miniminally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.